Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents
EuroIntervention 2017;13:1337-1345 published online August 2017. DOI: 10.4244/EIJ-D-17-00434
Lars Jakobsen1*, MD, PhD; Evald H. Christiansen1, MD, PhD; Michael Maeng1, MD, PhD; Knud N. Hansen2, MD; Steen D. Kristensen1, MD, DMSci; Hans E. Bøtker1, MD, DMSci, PhD; Christian J. Terkelsen1, MD, DMSci, PhD; Svend E. Jensen3, MD, PhD; Bent Raungaard3, MD, PhD; Morten Madsen4, MSc; Jens F. Lassen1, MD, PhD; Lisette O. Jensen2, MD, DMSci, PhD; for the SORT OUT (Scandinavian Organization for Randomized Trials with Clinical Outcome) V investigators
1. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark; 2. Department of Cardiology, Odense University Hospital, Odense, Denmark; 3. Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark; 4. Department of Clinical Epide
Aims: Our aim was to report the long-term safety and efficacy of the biodegradable polymer-coated biolimus-eluting Nobori stent compared to the durable polymer-coated sirolimus-eluting CY